Elucidation and Clinical Role of Emerging Viral Respiratory Tract Infections in Children

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

Acute respiratory viral infections (ARVI’s) are the most common infectious disease in humans. With the appearance of molecular techniques the recovery of viruses has dramatically increased. Nowadays virologists can quickly discriminate virological families and related viruses from emerging viruses and consequently identify novel viruses. Many new respiratory viruses have been identified in children in the past 15 years. In this review we shortly discuss novel respiratory viruses and their pathogenic role in pediatric respiratory disease. Advantages and drawbacks of the technique and our current knowledge will be discussed. We will conclude this review with a general discussion on the future role of molecular diagnostic virology in the clinic.

Keywords

Europe Pneumonia Influenza Meningitis Malaysia 

References

  1. 1.
    Ruuskanen O, Lahti E, Jennings LC, Murdoch DR (2011) Viral pneumonia. Lancet 377:1264–1275PubMedCrossRefGoogle Scholar
  2. 2.
    Glezen WP, Loda FA, Clyde Jr, Senior RJ, Sheaffer CI, Conley WG et al (1971) Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr 78:397–406PubMedCrossRefGoogle Scholar
  3. 3.
    Zalm van der MMM, Uiterwaal CPM, Wilbrink BP, de Jong BMM, Verheij TJM et al (2009) Respiratory Pathogens in Respiratory Tract Illnesses During the First Year of Life: A Birth Cohort Study. Pediatr Infect Dis J 28:472–476CrossRefGoogle Scholar
  4. 4.
    Henrickson KJ (1998) Viral pneumonia in children. Semin Pediatr Infect Dis 9:217–233CrossRefGoogle Scholar
  5. 5.
    Fabbiani M, Terrosi C, Martorelli B, Valentini M, Bernini L, Cellesi C et al (2009) Epidemiological and clinical study of viral respiratory tract infections in children from Italy. J Med Virol 81:750–756PubMedCrossRefGoogle Scholar
  6. 6.
    Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW (2003) Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 112:363–367PubMedCrossRefGoogle Scholar
  7. 7.
    Kumar D (2010) Emerging viruses in transplantation. Curr Opin Infect Dis 23:374–378PubMedGoogle Scholar
  8. 8.
    Fredericks DN, Relman DA (1996) Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Clin Microbiol Rev 9:18–33PubMedGoogle Scholar
  9. 9.
    Lipkin WI (2009) Microbe hunting in the 21st century. Proc Natl Acad Sci U S A 106:6–7PubMedCrossRefGoogle Scholar
  10. 10.
    Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, Rogers RJ et al (1995) Infection of humans and horses by a newly described morbillivirus. Med J Aust 162:642–645PubMedGoogle Scholar
  11. 11.
    Murray K, Rogers R, Selvey L, Selleck P, Hyatt A, Gould A et al (1995) A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg Infect Dis 1:31–33PubMedCrossRefGoogle Scholar
  12. 12.
    Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L et al (1995) A morbillivirus that caused fatal disease in horses and humans. Science 268:94–97PubMedCrossRefGoogle Scholar
  13. 13.
    Hess IMR, Massey PD, Walker B, Middleton DJ, Wright TM ( 2011) Hendra virus: what do we know? N S W Public Health Bull 22:118–122PubMedCrossRefGoogle Scholar
  14. 14.
    Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J (2001) The natural history of Hendra and Nipah viruses. Microbes Infect 3:307–314PubMedCrossRefGoogle Scholar
  15. 15.
    Chiang CF, Lo MK, Rota PA, Spiropoulou CF, Rollin PE (2010) Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA. Virol J 7:115PubMedCrossRefGoogle Scholar
  16. 16.
    CDC ( 1999) Outbreak of Hendra-like virus–Malaysia and Singapore, 1998–1999. MMWR Morb Mortal Wkly Rep 48:265–269Google Scholar
  17. 17.
    CDC (1999) Update: outbreak of Nipah virus–Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep 48:335–337Google Scholar
  18. 18.
    Lo MK, Rota PA (2008) The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol 43:396–400PubMedCrossRefGoogle Scholar
  19. 19.
    WHO (2010) Nipah virus fact sheet (revised in July 2009). Wkly Epidemiol Rec 85:64–67Google Scholar
  20. 20.
    Mounts AW, Kwong H, Izurieta HS, Ho Y, Au T, Lee M et al (1999) Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis 180:505–508PubMedCrossRefGoogle Scholar
  21. 21.
    Tan CT, Tan KS (2001) Nosocomial transmissibility of Nipah virus. J Infect Dis 184:1367PubMedCrossRefGoogle Scholar
  22. 22.
    Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA et al (2000) Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 342:1229–1235PubMedCrossRefGoogle Scholar
  23. 23.
    Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P et al (2004) Nipah virus: vaccination and passive protection studies in a hamster model. J Virol 78:834–840PubMedCrossRefGoogle Scholar
  24. 24.
    Daniels P, Ksiazek T, Eaton BT (2001) Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect 3:289–295PubMedCrossRefGoogle Scholar
  25. 25.
    Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT et al (2007) Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems. J Virol Methods 142:29–40PubMedCrossRefGoogle Scholar
  26. 26.
    (1997) Isolation of avian influenza A(H5N1) viruses from humans–Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep 46:1204–1207Google Scholar
  27. 27.
    Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H et al (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393–396PubMedCrossRefGoogle Scholar
  28. 28.
    Chen H, Smith GJ, Li KS, Wang J, Fan XH, Rayner JM et al (2006) Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A 103:2845–2850PubMedCrossRefGoogle Scholar
  29. 29.
    Webster RG, Govorkova EA (2006) H5N1 influenza–continuing evolution and spread. N Engl J Med 355:2174–2177PubMedCrossRefGoogle Scholar
  30. 30.
    Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC et al (2004) Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350:1179–1188PubMedCrossRefGoogle Scholar
  31. 31.
    Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD et al (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374–1385PubMedCrossRefGoogle Scholar
  32. 32.
    Kilpatrick AM, Chmura AA, Gibbons DW, Fleischer RC, Marra PP, Daszak P (2006) Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci U S A 103:19368–19373PubMedCrossRefGoogle Scholar
  33. 33.
    Ducatez MF, Olinger CM, Owoade AA, De Landtsheer S, Ammerlaan W, Niesters HG et al (2006) Avian flu: multiple introductions of H5N1 in Nigeria. Nature 442:37PubMedCrossRefGoogle Scholar
  34. 34.
    Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD et al (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358:261–273PubMedCrossRefGoogle Scholar
  35. 35.
    de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN et al (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12:1203–1207PubMedCrossRefGoogle Scholar
  36. 36.
    Schunemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, Hayden FG et al (2007) WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 7:21–31PubMedCrossRefGoogle Scholar
  37. 37.
    Girard MP, Osterhaus A, Pervikov Y, Palkonyay L, Kieny MP (2008) Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3–4 December 2007. Vaccine 26:2443–2450PubMedCrossRefGoogle Scholar
  38. 38.
    van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R et al (2003) Prevalence and Clinical Symptoms of Human Metapneumovirus Infection in Hospitalized Patients. The J Infect Dis 188:1571–1577CrossRefGoogle Scholar
  39. 39.
    Brodzinski H, Ruddy RM (2009) Review of new and newly discovered respiratory tract viruses in children. Pediatr Emerg Care 25:352–360; quiz 61–3PubMedCrossRefGoogle Scholar
  40. 40.
    Viazov S, Ratjen F, Scheidhauer R, Fiedler M, Roggendorf M (2003) High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol 41:3043–3045PubMedCrossRefGoogle Scholar
  41. 41.
    Dollner H, Risnes K, Radtke A, Nordbo SA (2004) Outbreak of human metapneumovirus infection in norwegian children. Pediatr Infect Dis J 23:436–440PubMedCrossRefGoogle Scholar
  42. 42.
    Maggi F, Pifferi M, Vatteroni M, Fornai C, Tempestini E, Anzilotti S et al (2003) Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol 41:2987–2991PubMedCrossRefGoogle Scholar
  43. 43.
    Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM et al (2004) Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children. N Engl J Med 350:443–450PubMedCrossRefGoogle Scholar
  44. 44.
    Pelletier G, Dery P, Abed Y, Boivin G (2002) Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child. Emerg Infect Dis 8:976–978PubMedCrossRefGoogle Scholar
  45. 45.
    Kahn JS (2006) Epidemiology of Human Metapneumovirus. Clin Microbiol Rev 19:546–557PubMedCrossRefGoogle Scholar
  46. 46.
    Papenburg J, Boivin G (2010) The distinguishing features of human metapneumovirus and respiratory syncytial virus. Rev Med Virol 20:245–260PubMedCrossRefGoogle Scholar
  47. 47.
    Garcia DF, Hiatt PW, Jewell A, Schoonover SL, Cron SG, Riggs M et al (2007) Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatr Pulmonol 42:66–74PubMedCrossRefGoogle Scholar
  48. 48.
    Landry ML, Cohen S, Ferguson D (2008) Prospective study of human metapneumovirus detection in clinical samples by use of light diagnostics direct immunofluorescence reagent and real-time PCR. J Clin Microbiol 46:1098–1100PubMedCrossRefGoogle Scholar
  49. 49.
    Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M et al (2004) Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 42:981–986PubMedCrossRefGoogle Scholar
  50. 50.
    Tyrell DJ, Struve FA, Schwartz ML (1965) A methodological consideration in the performance of process and reactive schizophrenics on a test for organic brain pathology. J Clin Psychol 21:254–256PubMedCrossRefGoogle Scholar
  51. 51.
    Hamre D, Procknow JJ (1966) A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 121:190–193PubMedGoogle Scholar
  52. 52.
    McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM (1967) Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A 57:933–940PubMedCrossRefGoogle Scholar
  53. 53.
    van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC et al (2004) Identification of a new human coronavirus. Nat Med 10:368–373PubMedCrossRefGoogle Scholar
  54. 54.
    Boivin G, Coulombe Z, Wat C (2003) Quantification of the influenza virus load by real-time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir. J InfectDis 188:578–580CrossRefGoogle Scholar
  55. 55.
    van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF et al (2005) Croup is associated with the novel coronavirus NL63. PLoS Med 2:e240PubMedCrossRefGoogle Scholar
  56. 56.
    Bastien N, Robinson JL, Tse A, Lee BE, Hart L, Li Y (2005) Human coronavirus NL-63 infections in children: a 1-year study. J Clin Microbiol 43:4567–4573PubMedCrossRefGoogle Scholar
  57. 57.
    Bastien N, Anderson K, Hart L, Van Caeseele P, Brandt K, Milley D et al (2005) Human coronavirus NL63 infection in Canada. J Infect Dis 191:503–506PubMedCrossRefGoogle Scholar
  58. 58.
    Arden KE, Nissen MD, Sloots TP, Mackay IM (2005) New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 75:455–462PubMedCrossRefGoogle Scholar
  59. 59.
    Han TH, Chung JY, Kim SW, Hwang ES (2007) Human Coronavirus-NL63 infections in Korean children, 2004–2006. J Clin Virol 38:27–31PubMedCrossRefGoogle Scholar
  60. 60.
    Gerna G, Vitulo P, Rovida F, Lilleri D, Pellegrini C, Oggionni T et al (2006) Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 78:408–416PubMedCrossRefGoogle Scholar
  61. 61.
    Pfefferle S, Schopf J, Kogl M, Friedel CC, Muller MA, Carbajo-Lozoya J et al (2011) The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors. PLoS Pathog 7:e1002331PubMedCrossRefGoogle Scholar
  62. 62.
    Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y et al (2005) Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884–895PubMedCrossRefGoogle Scholar
  63. 63.
    Ren L, Gonzalez R, Xu J, Xiao Y, Li Y, Zhou H et al (2011) Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing, China. J Med Virol 83:291–297PubMedCrossRefGoogle Scholar
  64. 64.
    Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS (2006) Coronavirus HKU1 infection in the United States. Emerg Infect Dis 12:775–779PubMedCrossRefGoogle Scholar
  65. 65.
    Vijgen L, Moes E, Keyaerts E, Li S, Van Ranst M (2008) A pancoronavirus RT-PCR assay for detection of all known coronaviruses. Methods Mol Biol 454:3–12PubMedCrossRefGoogle Scholar
  66. 66.
    Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B (2005) Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 102:12891–12896PubMedCrossRefGoogle Scholar
  67. 67.
    Longtin J, Bastien M, Gilca R, Leblanc E, de Serres G, Bergeron MG et al (2008) Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis 14:217–221PubMedCrossRefGoogle Scholar
  68. 68.
    Arnold JC, Singh KK, Spector SA, Sawyer MH (2006) Human bocavirus: prevalence and clinical spectrum at a children’s hospital. Clin Infect Dis 43:283–288PubMedCrossRefGoogle Scholar
  69. 69.
    van de Pol AC, Wolfs TF, Jansen NJ, Kimpen JL, van Loon AM, Rossen JW (2009) Human bocavirus and KI/WU polyomaviruses in pediatric intensive care patients. Emerg Infect Dis 15:454–457PubMedCrossRefGoogle Scholar
  70. 70.
    Allander T, Jartti T, Gupta S, Niesters HG, Lehtinen P, Osterback R et al (2007) Human bocavirus and acute wheezing in children. Clin Infect Dis 44:904–910PubMedCrossRefGoogle Scholar
  71. 71.
    Allander T (2008) Human bocavirus. J Clin Virol 41:29–33PubMedCrossRefGoogle Scholar
  72. 72.
    Lu X, Chittaganpitch M, Olsen SJ, Mackay IM, Sloots TP, Fry AM et al (2006) Real-time PCR assays for detection of bocavirus in human specimens. J Clin Microbiol 44:3231–3235PubMedCrossRefGoogle Scholar
  73. 73.
    Soderlund-Venermo M, Lahtinen A, Jartti T, Hedman L, Kemppainen K, Lehtinen P et al (2009) Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis 15:1423–1430PubMedCrossRefGoogle Scholar
  74. 74.
    Dijkman R, Koekkoek SM, Molenkamp R, Schildgen O, van der Hoek L (2009) Human bocavirus can be cultured in differentiated human airway epithelial cells. J Virol 83:7739–7748PubMedCrossRefGoogle Scholar
  75. 75.
    Wigand R, Sabin AB (1961) Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch 11:224–247PubMedCrossRefGoogle Scholar
  76. 76.
    Baumgarte S, de Souza Luna LK, Grywna K, Panning M, Drexler JF, Karsten C et al (2008) Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis. J Clin Microbiol 46:242–248PubMedCrossRefGoogle Scholar
  77. 77.
    Benschop KS, Schinkel J, Luken ME, van den Broek PJ, Beersma MF, Menelik N et al (2006) Fourth human parechovirus serotype. Emerg Infect Dis 12:1572–1575PubMedCrossRefGoogle Scholar
  78. 78.
    Al-Sunaidi M, Williams CH, Hughes PJ, Schnurr DP, Stanway G (2007) Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains. J Virol 81:1013–1021PubMedCrossRefGoogle Scholar
  79. 79.
    Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K (2004) Isolation and identification of a novel human parechovirus. J Gen Virol 85:391–398PubMedCrossRefGoogle Scholar
  80. 80.
    Harvala H, Robertson I, McWilliam Leitch EC, Benschop K, Wolthers KC, Templeton K et al (2008) Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol 46:3446–3453PubMedCrossRefGoogle Scholar
  81. 81.
    Schnurr D, Dondero M, Holland D, Connor J (1996) Characterization of echovirus 22 variants. Arch Virol 141:1749–1758PubMedCrossRefGoogle Scholar
  82. 82.
    Watanabe K, Oie M, Higuchi M, Nishikawa M, Fujii M (2007) Isolation and characterization of novel human parechovirus from clinical samples. Emerg Infect Dis 13:889–895PubMedCrossRefGoogle Scholar
  83. 83.
    Chieochansin T, Vichiwattana P, Korkong S, Theamboonlers A, Poovorawan Y (2011) Molecular epidemiology, genome characterization, and recombination event of human parechovirus. Virology 421:159–166PubMedCrossRefGoogle Scholar
  84. 84.
    Pajkrt D, Benschop KS, Westerhuis B, Molenkamp R, Spanjerberg L, Wolthers KC (2009) Clinical characteristics of human parechoviruses 4–6 infections in young children. Pediatr Infect Dis J 28:1008–1010PubMedCrossRefGoogle Scholar
  85. 85.
    Harvala H, Robertson I, Chieochansin T, McWilliam Leitch EC, Templeton K, Simmonds P (2009) Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis 199:1753–1760PubMedCrossRefGoogle Scholar
  86. 86.
    Harvala H, Wolthers KC, Simmonds P (2010) Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis 23:224–230PubMedCrossRefGoogle Scholar
  87. 87.
    Nix WA, Maher K, Johansson ES, Niklasson B, Lindberg AM, Pallansch MA et al (2008) Detection of all known parechoviruses by real-time PCR. J Clin Microbiol 46:2519–2524PubMedCrossRefGoogle Scholar
  88. 88.
    Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA et al (2007) Identification of a third human polyomavirus. J Virol 81:4130–4136PubMedCrossRefGoogle Scholar
  89. 89.
    Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G et al (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3:e64PubMedCrossRefGoogle Scholar
  90. 90.
    Nguyen NL, Le BM, Wang D (2009) Serologic evidence of frequent human infection with WU and KI polyomaviruses. Emerg Infect Dis 15:1199–1205PubMedCrossRefGoogle Scholar
  91. 91.
    Abed Y, Wang D, Boivin G (2007) WU polyomavirus in children, Canada. Emerg Infect Dis 13:1939–1941PubMedCrossRefGoogle Scholar
  92. 92.
    Norja P, Ubillos I, Templeton K, Simmonds P (2007) No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol 40:307–311PubMedCrossRefGoogle Scholar
  93. 93.
    Han TH, Chung JY, Koo JW, Kim SW, Hwang ES (2007) WU polyomavirus in children with acute lower respiratory tract infections, South Korea. Emerg Infect Dis 13:1766–1768PubMedCrossRefGoogle Scholar
  94. 94.
    Babakir-Mina M, Ciccozzi M, Perno CF, Ciotti M (2011) The novel KI, WU, MC polyomaviruses: possible human pathogens? New Microbiol 34:1–8PubMedGoogle Scholar
  95. 95.
    Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ et al (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615PubMedCrossRefGoogle Scholar
  96. 96.
    Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201PubMedCrossRefGoogle Scholar
  97. 97.
    Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N et al (2010) Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362:45–55PubMedCrossRefGoogle Scholar
  98. 98.
    Farias JA, Fernandez A, Monteverde E, Vidal N, Arias P, Montes MJ et al (2010) Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med 36(6):1015–1022 (Epub 2010 Mar 18)Google Scholar
  99. 99.
    Bishop JF, Murnane MP, Owen R (2009) Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 361:2591–2594PubMedCrossRefGoogle Scholar
  100. 100.
    Lister P, Reynolds F, Parslow R, Chan A, Cooper M, Plunkett A et al (2009) Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 374:605–607PubMedCrossRefGoogle Scholar
  101. 101.
    Patel M, Dennis A, Flutter C, Khan Z (2010) Pandemic (H1N1) 2009 influenza. Br J Anaesth 104:128–142PubMedCrossRefGoogle Scholar
  102. 102.
    Giannella M, Alonso M, Garcia de Viedma D, Lopez Roa P, Catalan P, Padilla B et al (2011) Prolonged viral shedding in pandemic influenza A (H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect 17:1160–1165PubMedCrossRefGoogle Scholar
  103. 103.
    Bennett S, Gunson RN, MacLean A, Miller R, Carman WF (2011) The validation of a real- time RT-PCR assay which detects influenza A and types simultaneously for influenza A H1N1 (2009) and oseltamivir-resistant (H275Y) influenza A H1N1 (2009). J Virol Methods 171:86–90PubMedCrossRefGoogle Scholar
  104. 104.
    Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L et al (2009) Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 45:191–195PubMedCrossRefGoogle Scholar
  105. 105.
    Faix DJ, Sherman SS, Waterman SH (2009) Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 361:728–729PubMedCrossRefGoogle Scholar
  106. 106.
    Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R (2011) Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Adv Ther 28:927–959PubMedCrossRefGoogle Scholar
  107. 107.
    Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M et al (2011) Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010. Antiviral Res 92:81–89PubMedCrossRefGoogle Scholar
  108. 108.
    Arguedas A, Soley C, Lindert K (2010) Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. N Engl J Med 362:370–372PubMedCrossRefGoogle Scholar
  109. 109.
    Lambert LC, Fauci AS (2010) Influenza vaccines for the future. N Engl J Med 363:2036–2044PubMedCrossRefGoogle Scholar
  110. 110.
    Wu J, Xu F, Lu L, Lu M, Miao L, Gao T et al (2010) Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 363:2416–2423PubMedCrossRefGoogle Scholar
  111. 111.
    Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N et al (2011) Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. VaccineGoogle Scholar
  112. 112.
    (2011) Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case- control study. BMJ Open 1:e000167Google Scholar
  113. 113.
    van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA et al. (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719–724PubMedCrossRefGoogle Scholar
  114. 114.
    Sloots TP, Whiley DM, Lambert SB, Nissen MD (2008) Emerging respiratory agents: new viruses for old diseases? J Clin Virol 42:233–243PubMedCrossRefGoogle Scholar
  115. 115.
    Bosis S, Esposito S, Osterhaus AD, Tremolati E, Begliatti E, Tagliabue C et al (2008) Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infection. J Clin Virol 42:286–290PubMedCrossRefGoogle Scholar
  116. 116.
    Semple MG, Dankert HM, Ebrahimi B, Correia JB, Booth JA, Stewart JP et al (2007) Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS One 2:e1038PubMedCrossRefGoogle Scholar
  117. 117.
    Gerna G, Campanini G, Rognoni V, Marchi A, Rovida F, Piralla A et al (2008) Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. J Clin Virol 41:45–48PubMedCrossRefGoogle Scholar
  118. 118.
    McCullers JA (2006) Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:571–582PubMedCrossRefGoogle Scholar
  119. 119.
    McErlean P, Shackelton LA, Lambert SB, Nissen MD, Sloots TP, Mackay IM ( 2007) Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis. J Clin Virol 39:67–75PubMedCrossRefGoogle Scholar
  120. 120.
    Peltola V, Heikkinen T, Ruuskanen O, Jartti T, Hovi T, Kilpi T et al (2011) Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J 30:456–461PubMedGoogle Scholar
  121. 121.
    Heikkinen T, Osterback R, Peltola V, Jartti T, Vainionpaa R (2008) Human metapneumovirus infections in children. Emerg Infect Dis 14:101–106PubMedCrossRefGoogle Scholar
  122. 122.
    Aberle JH, Aberle SW, Redlberger-Fritz M, Sandhofer MJ, Popow-Kraupp T (2010) Human metapneumovirus subgroup changes and seasonality during epidemics. Pediatr Infect Dis J 29:1016–1018PubMedGoogle Scholar
  123. 123.
    Mullins JA, Erdman DD, Weinberg GA, Edwards K, Hall CB, Walker FJ et al (2004) Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 10:700–705PubMedCrossRefGoogle Scholar
  124. 124.
    Chen X, Zhang ZY, Zhao Y, Liu EM, Zhao XD (2010) Acute lower respiratory tract infections by human metapneumovirus in children in Southwest China: a 2-year study. Pediatr Pulmonol 45:824–831PubMedCrossRefGoogle Scholar
  125. 125.
    Manoha C, Bour JB, Pitoiset C, Darniot M, Aho S, Pothier P (2008) Rapid and sensitive detection of metapneumovirus in clinical specimens by indirect fluorescence assay using a monoclonal antibody. J Med Virol 80:154–158PubMedCrossRefGoogle Scholar
  126. 126.
    Williams J-V, Edwards K-M, Weinberg G-A, Griffin M-R, Hall C-B, Zhu Y et al (2010) Population Based Incidence of Human Metapneumovirus Infection among Hospitalized Children. J Infect Dis 201:1890–1898PubMedCrossRefGoogle Scholar
  127. 127.
    Bosis S, Esposito S, Niesters HG, Crovari P, Osterhaus AD, Principi N (2005) Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol 75:101–104PubMedCrossRefGoogle Scholar
  128. 128.
    Hackett S, Hill L, Patel J, Ratnaraja N, Ifeyinwa A, Farooqi M et al (2009) Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 374:605PubMedCrossRefGoogle Scholar
  129. 129.
    Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361:1935–1944PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of PediatricsRadboud University Medical CentreNijmegenThe Netherlands

Personalised recommendations